Omada Health (OMDA) Stock Price

Omada Health Price

NYSE·CLOSED
19.68
​
Market closed

Revenue has compounded at 44.7% per year over the past 3 years to 257.68 M USD. Omada Health's net margin stands at -5.0%, up from -85.3% several years earlier. Analysts set a median price target of 25.00 USD, implying 27.0% above the current price. Of 18 analysts, 15 rate the stock a buy — an overall Buy consensus.

Omada Health stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Omada Health business model & stock analysis

Omada Health, Inc. engages in the provision of digital health services. The company is headquartered in San Francisco, California and currently employs 859 full-time employees. The company went IPO on 2025-06-06. The firm has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. The company offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.

Frequently asked questions about Omada Health

Analysts currently set an average price target of 25.63 USD for the Omada Health stock (median: 25.00 USD), implying +30.2 % versus the latest price. The consensus is based on 18 analyst ratings.

18 analysts currently rate the Omada Health stock: 15 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Omada Health to generate revenue of 338.71 M USD and earnings per share of 0.33 USD.

Converted at the current exchange rate, the Omada Health share trades at 17.55 EUR (19.68 USD).

The expected revenue of Omada Health is 338.71 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Omada Health is 19.03 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Omada Health is currently 60.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Omada Health stock.

The price-to-sales ratio (P/S) of Omada Health is currently 3.39. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Omada Health stock.

The Eulerpool Quality Score for Omada Health is 3/10.

The ISIN of Omada Health is US68170A1088. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Omada Health is OMDA. The ticker symbol is used to trade Omada Health shares on the stock exchange.

Fair ValueTerminal
20.47 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
281,305.68 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jun 6, 2025
ISIN
US68170A1088
Cusip
68170A108
Market capitalization
1.14 B USDSmall Cap
52-Week Range
PEG
-2.48
P/E ratio
P/Ee 2026
59.90
P/Ee 2027
44.10
P/Ee 2028
23.65
P/Ee 2029
—
P/Ee 2030
—
P/S
P/Se
3.39
EV/EBIT
—
P/B Ratio
4.96
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.56 %
Last updated Oct 23, 2026, 7:17 AM

Omada Health Peer Group

All fundamentals and in-depth analysis of Omada Health

Our stock analysis for Omada Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Omada Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.